Combinatorial treatment with Gefitinib and Bay11-7085 sensitizes primary Gefitinib-resistant OSCC cells by influencing the EGFR- NFκB signaling axis
Crossref DOI link: https://doi.org/10.1007/s12032-021-01557-z
Published Online: 2021-08-06
Published Print: 2021-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sinto, M. S.
Thomas, Shaji
Kannan, S. http://orcid.org/0000-0001-8833-9620
Funding for this research was provided by:
Kerala State Council for Science, Technology and Environment (723/2014/KSCSTE)
Text and Data Mining valid from 2021-08-06
Version of Record valid from 2021-08-06
Article History
Received: 13 February 2021
Accepted: 13 July 2021
First Online: 6 August 2021